Quest Diagnostics Inc (DGX)

DGX (NYSE:Health Services) EQUITY
$73.49
neg -0.17
-0.23%
Today's Range: 72.96 - 73.65 | DGX Avg Daily Volume: 1,480,200
Last Update: 07/30/15 - 4:02 PM EDT
Volume: 427,101
YTD Performance: 9.84%
Open: $73.48
Previous Close: $73.66
52 Week Range: $56.27 - $89.00
Oustanding Shares: 143,636,295
Market Cap: 10,359,049,595
6-Month Chart
TheStreet Ratings Grade for DGX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 3 2 2
Moderate Buy 0 0 0 0
Hold 12 14 14 14
Moderate Sell 1 1 1 1
Strong Sell 2 2 2 2
Mean Rec. 2.91 2.92 3.02 3.02
Latest Dividend: 0.38
Latest Dividend Yield: 2.11%
Dividend Ex-Date: 07/06/15
Price Earnings Ratio: 18.21
Price Earnings Comparisons:
DGX Sector Avg. S&P 500
18.21 21.10 25.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.95% 18.35% 25.31%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.00 -0.01 0.00
Net Income -33.00 0.16 0.05
EPS -31.20 0.30 0.09
Earnings for DGX:
EBITDA 1.29B
Revenue 7.44B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $1.27 $1.21 $4.75 $5.09
Number of Analysts 13 12 14 14
High Estimate $1.30 $1.24 $4.82 $5.31
Low Estimate $1.23 $1.16 $4.45 $4.70
Prior Year $1.10 $1.08 $4.10 $4.75
Growth Rate (Year over Year) 15.24% 11.65% 15.94% 7.17%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Selling covered calls and naked puts can reduce risk. (Updated)
Light volume precedes break for Memorial Day.
Major indices continue to show little movement as we approached the noon hour, although they have turned down in the last half hour. I can't recall such a flat week this year. Maybe everyone is already in the Hamptons and it is just the computers trading with each other.
Update
Mar 27, 2015 | 7:59 AM EDT
Coverage of DGX was started with a Market Perform, JMP Securities said. Company is facing macro headwinds. 
Bearish
Mar 25, 2015 | 7:22 AM EDT
DGX was downgraded from Buy to Hold, Deutsche Bank said. Valuation call, based on an $80 price target.
Here are healthcare stocks of all shares and sizes with strong charts.
Bullish
Mar 03, 2015 | 5:49 AM EST
DGX was upgraded from Hold to Buy, Canaccord Genuity said. $82 price target. Company is cutting costs and should see higher test volume...
Bearish
Feb 23, 2015 | 7:24 AM EST
DGX was downgraded to Underperform, Bank of America/Merrill Lynch said. $68 price target. Company appears to be growth slower than top ...

Get Some Positive Lab Results Real Money Pro($)

Try this options play for the sometimes volatile Bio-Reference Laboratories.

Columnist Conversations

$455 million to sell on the close.
Market is giving back some of its gains of the last two sessions. With slightly over half of the S&P 500 r...
After three straight gains, on accelerating trade, PFE is pulling back. At yesterday's high the stock had ...
The IMF/Greece news triggers higher bond prices, lower yields.

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.